Goetz Danielle M, Singh Shipra, Sheehan Daniel
Department of Pediatrics, University at Buffalo, State University of New York, USA.
Respir Med Case Rep. 2015 Sep 21;16:125-7. doi: 10.1016/j.rmcr.2015.09.009. eCollection 2015.
Cystic fibrosis (CF) causes airways obstruction and a decline in percent predicted forced expiratory volume in 1 s (FEV1%). FEV1% is an objective measure of a pulmonary exacerbation of CF; improvement in FEV1% is the endpoint used often to determine success of treatment of these acute declines in pulmonary health. Lung Clearance Index (LCI), derived from multiple breath inert gas washout (MBW) test, measures ventilation inhomogeneity and small airways dysfunction. In the United States in 2014-2015, enterovirus D68 (EV-D68), a novel virus, led to hospitalizations in children because of respiratory distress. This report describes 2 patients with CF admitted for pulmonary exacerbations who were enrolled in an inpatient study to assess patient satisfaction and utility of MBW to measure LCI. Diagnostic testing indicated that these patients were infected with EV-D68. Although their FEV1% improved to their previous baseline following treatment for pulmonary exacerbation, it was discordant with LCI. We discuss LCI as a novel measure of pulmonary function and hypothesize that, based on these cases, it may be a more sensitive indicator of ongoing post-viral airways dysfunction as compared to FEV1%.
囊性纤维化(CF)会导致气道阻塞以及预测的1秒用力呼气容积百分比(FEV1%)下降。FEV1%是CF肺部加重的客观指标;FEV1%的改善是常用于确定这些肺部健康急性下降治疗成功与否的终点。肺清除指数(LCI)源自多次呼吸惰性气体洗脱(MBW)测试,用于测量通气不均匀性和小气道功能障碍。2014 - 2015年在美国,一种新型病毒——肠道病毒D68(EV - D68)导致儿童因呼吸窘迫而住院。本报告描述了2例因肺部加重入院的CF患者,他们参与了一项住院研究,以评估患者满意度以及MBW测量LCI的效用。诊断测试表明这些患者感染了EV - D68。尽管他们的FEV1%在肺部加重治疗后恢复到之前的基线水平,但与LCI不一致。我们将LCI作为一种新型肺功能指标进行讨论,并基于这些病例推测,与FEV1%相比,它可能是病毒感染后持续气道功能障碍更敏感的指标。